GlassScriptPhysician profile
Brian Dierckman
NPI 1447436266
$171,948.78
in general payments reported to CMS, 2019-2025
22 companies · $9,113 in 2025
The $9,113 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $14K · 2021: $36K · 2022: $33K · 2023: $33K · 2024: $28K · 2025: $9,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Consulting Fee: $11K · Travel and Lodging: $7,091 · Food and Beverage: $2,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,537.50 |
| Consulting Fee | $11,050.00 |
| Travel and Lodging | $7,090.63 |
| Food and Beverage | $2,838.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $152,612.74 | 2019-2025 | Arthrex |
| Alpha Orthopedic Systems | $9,600.53 | 2019-2024 | |
| Smith+Nephew, INC. | $4,035.97 | 2019-2025 | Real Intelligence, Journey II, Redapt |
| Depuy Synthes Products, INC. | $2,227.50 | 2020-2021 | |
| Medical Device Business Services, INC. | $1,501.36 | 2019-2025 | Healix Knotless Peek, Vapr, Dynacord |
| Biotissue Holdings INC. | $460.61 | 2024-2025 | |
| Music City Medical Technologies, LLC | $273.40 | 2024-2025 | |
| Linvatec Corporation | $236.66 | 2019-2023 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $212.71 | 2019-2021 | |
| Supreme Orthopedic Systems, LLC | $157.01 | 2022 | |
| Joint Restoration Foundation, INC. | $116.29 | 2025 | |
| Stryker Corporation | $112.58 | 2022-2025 | 1788 |
| Zimmer Biomet Holdings, INC. | $100.66 | 2019 | |
| Medacta USA, INC. | $100.00 | 2021 | |
| Vericel Corporation | $54.29 | 2023-2024 | Maci |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biorez, INC. | $32.59 | 2022 | |
| Convatec INC. | $26.29 | 2024 | |
| Innovation Technologies INC | $21.83 | 2025 | Irrisept |
| Abbott Laboratories | $20.58 | 2025 | Octrode |
| Orthofix Medical, INC. | $17.91 | 2025 | Physio-Stim |
| Bioventus LLC | $14.44 | 2025 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dierckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.